Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
暂无分享,去创建一个
K. Preissner | J. Henkin | D. Cines | D. Strickland | R. Cohen | K. McCrae | M. Kounnas | R. Upson | J. Manuppello | J. Bognacki | A. Higazi | J. Lawler | Jack Henkin | Dudley K. Strickland | Abd A I Roof Higazi | K. T. Preissner | Rosalyn H. Upson | Robert L. Cohen | Joseph Manuppello | John Bognacki | Keith R. McCrae | Jack Lawler | D. Strickland
[1] K. Preissner,et al. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. , 1996, Experimental cell research.
[2] H. Petty,et al. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization. , 1996, Journal of immunology.
[3] R. Pardi,et al. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor , 1995, The Journal of cell biology.
[4] J. Henkin,et al. Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor (*) , 1995, The Journal of Biological Chemistry.
[5] T. L. Moser,et al. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. , 1995, The Biochemical journal.
[6] S. Rosenberg,et al. Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.
[7] S. Schultz-Cherry,et al. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. , 1994, The Journal of biological chemistry.
[8] D. Lawrence,et al. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. , 1994, The Journal of biological chemistry.
[9] S. Waxman,et al. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells , 1994, The Journal of cell biology.
[10] D. Waltz,et al. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. , 1994, The Journal of biological chemistry.
[11] H. Petty,et al. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. , 1994, Journal of immunology.
[12] W. Schleuning,et al. Induction of c‐fos gene expression by urokinase‐type plasminogen activator in human ovarian cancer cells , 1994, FEBS letters.
[13] M. Gyetko,et al. The urokinase receptor is required for human monocyte chemotaxis in vitro. , 1994, The Journal of clinical investigation.
[14] H. Li,et al. Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor. , 1994, The Journal of biological chemistry.
[15] N. Brünner,et al. Confocal fluorescence microscopy of urokinase plasminogen activator receptor and cathepsin D in human MDA-MB-231 breast cancer cells migrating in reconstituted basement membrane. , 1994, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[16] A. Copeta,et al. Plasminogen activators as growth factorsof human fibroblasts , 1994 .
[17] A. Mazar,et al. Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[18] A. Mazar,et al. Urokinase inhibits HL-60 cell proliferation in vitro. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[19] K. Danø,et al. A novel, specific pro‐urokinase complex on monocyte‐like cells, detected by transglutaminase‐catalyzed cross‐linking , 1993, FEBS letters.
[20] J. Henkin,et al. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. , 1993, The Journal of biological chemistry.
[21] A. Levinson,et al. Prevention of metastasis by inhibition of the urokinase receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] W. Schleuning,et al. Interaction of urokinase‐type plasminogenactivator (u‐PA) with its cellular receptor (u‐PAR) induces phosphorylation on tyrosine of a 38 kDa protein , 1993, FEBS letters.
[23] D. Waltz,et al. Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. , 1993, The Journal of clinical investigation.
[24] M. Ruggiero,et al. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. , 1993, Biochemical and biophysical research communications.
[25] R. Hammer,et al. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation , 1992, Cell.
[26] K. Skorstengaard,et al. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin , 1992, The Journal of cell biology.
[27] S. Moestrup,et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.
[28] A. Mazar,et al. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. , 1992, The Journal of biological chemistry.
[29] D. Strickland,et al. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. , 1992, The Journal of biological chemistry.
[30] D. Rifkin,et al. Urokinase‐type plasminogen activator mediates basic fibroblast growth factor‐induced bovine endothelial cell migration independent of its proteolytic activity , 1992, Journal of cellular physiology.
[31] A. Petros,et al. Domain analysis of urokinase plasminogen activator (u-PA): Preparation and characterization of intact A-chain molecules , 1992 .
[32] B. Schwartz,et al. Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes. , 1991, The Journal of biological chemistry.
[33] H. Chapman,et al. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. , 1991, The Journal of clinical investigation.
[34] F. Blasi,et al. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. , 1991, The Journal of biological chemistry.
[35] L. Orci,et al. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.
[36] R. Silverstein,et al. Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. , 1990, The Journal of biological chemistry.
[37] L. Magnelli,et al. Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator. , 1990, Experimental cell research.
[38] L. Rosenfeld,et al. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. , 1990, The Journal of biological chemistry.
[39] M. Scully,et al. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.
[40] J. Kreisberg,et al. Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells. , 1988, The Journal of clinical investigation.
[41] L. Magnelli,et al. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. , 1988, Experimental cell research.
[42] R. Hynes,et al. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors , 1988, The Journal of cell biology.
[43] D. Mosher,et al. Conformational change in thrombospondin induced by removal of bound Ca2+ A spin label approach , 1988, FEBS letters.
[44] A. Vaheri,et al. Ultrastructural localization of plasma membrane-associated urokinase- type plasminogen activator at focal contacts , 1988, The Journal of cell biology.
[45] A. Gee,et al. Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. , 1987, Journal of immunology.
[46] G. Dini,et al. Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells , 1987, British journal of haematology.
[47] E. Appella,et al. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.
[48] E. Appella,et al. The Receptor-Binding Sequence of Urokinase , 1987 .
[49] K. Fujikawa,et al. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. , 1986, The Journal of biological chemistry.
[50] V. Dixit,et al. Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. , 1986, The Journal of biological chemistry.
[51] K. Preissner,et al. Physicochemical characterization of human S-protein and its function in the blood coagulation system. , 1985, The Biochemical journal.
[52] T. Suyama,et al. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. , 1985, The Journal of biological chemistry.
[53] J. Connolly,et al. The structure of human platelet thrombospondin. , 1985, The Journal of biological chemistry.
[54] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[55] J. Lawler,et al. Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. , 1983, The Journal of biological chemistry.